Pharmafile Logo
Pharmafocus logo
Advanced Search

marketing

Showing 15 posts of 86 posts found.

Working Life: Kay Spiller

February 13, 2009
Sales and Marketing Astellas Pharma Europe, marketing

How did you find your way into your role? This was really through what I would describe as the 'traditional' …

Feature

The Brand MOT

February 3, 2009
Sales and Marketing branding, marketing

To have a car on the road once it's more than three years old requires an MOT – an annual …

Feature

Who owns the brand?

January 27, 2009
Sales and Marketing branding, marketing

For all of us in brand marketing, it is worth remembering that creating and nurturing a brand can be like …

Feature

New sales and marketing models

January 21, 2009
Sales and Marketing marketing, sales, strategy

These are challenging times for pharma as regulatory reform, intense financial pressures and an increasingly complex network of stakeholders are …

Feature

What it takes to be a European marketing manager

January 20, 2009
Business Services, Sales and Marketing Europe, brand manager, management, marketing, recruitment

Moving from a country-specific marketing role to a European marketing role can open up a whole new career path and …

Feature

The ABPI Code: more to come in 2009

December 15, 2008
Medical Communications, Sales and Marketing ABPI, code, marketing

Is UK pharma coping with the revised Code and what changes will 2009 bring?  

Feature

Managed Entry: creating a dialogue ahead of your launch

November 17, 2008
Sales and Marketing NHS, healthcare, managed entry, marketing, product launch

Pharmaceutical companies are increasingly looking to 'managed entry' programmes to build strong relationships with NHS customers and ensure new products …

Feature

Specialising for success

October 29, 2008
Research and Development, Sales and Marketing marketing, product portfolio

From the middle of the last century, the likes of GSK, Pfizer, AstraZeneca, Bristol Myers Squibb and others have made …

Feature

Working Life: Amanda Moosa

September 18, 2008
Business Services, Sales and Marketing Nycomed, Working Life, branding, careers, marketing, sales

 How did you find your way into your current role?I came into things via the ‘traditional’ route. After my biochemistry …

Feature

Living with the Code of Practice

September 4, 2008
Medical Communications, Sales and Marketing ABPI, UK, code, marketing, pharma

The 2008 edition of the ABPI Code of Practice came into force on 1 July and the industry is fairly …

Feature

Marketing effectiveness: cloudy thinking won’t cut it

July 15, 2008
Sales and Marketing effectiveness, marketing

Over recent years the pharmaceutical industry has been unable to escape the mantra of return on investment (ROI). Investment in …

Feature

New customers in the new NHS

July 10, 2008
Sales and Marketing NHS, industry relations, marketing

No-one in pharmaceuticals or the NHS needs to be told their world is changing dramatically. The proof is all around, …

Feature

One problem, many solutions: understanding European healthcare

June 30, 2008
Sales and Marketing Europe, healthcare, marketing

Feature

Global marketing and the shifting balance of power

June 23, 2008
Sales and Marketing US, global, marketing

As a marketer in the international pharmaceutical world, it is very likely that the brand we are responsible for has …

Feature

7 principles in marketing to the new NHS

May 28, 2008
Sales and Marketing NHS, healthcare, marketing

Developing a successful market access strategy has become the Holy Grail for brand teams across the UK pharmaceutical industry.

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026